Concepedia

Author

Sridhar Vempati

Dana-Farber Cancer Institute

Also Known As

S Vempati, S. Vempati, Sridhar Vempati, Vempati, Sridhar

33

Publications

1.8K

Citations

8

H-Index

10

Concepts

All Affiliations

Dana-Farber Cancer InstituteLudwig-Maximilians-Universität MünchenHarvard Stem Cell InstituteMunich Leukemia Laboratory (Germany)Harvard University
SV

About

Sridhar Vempati is an author at Dana-Farber Cancer Institute specializing in tumor biology, chromatin, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

1.4K

2

Cell Biology

2

2

1.4K

3

Epigenetics

2

2

1.4K

4

Cancer Cell Biology

1

1

883

5

Systems Biology

1

1

883

Sridhar Vempati

×

7

Publications

1.8K

Citations

7

H-Index

YearCitations

MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L

Kathrin M. Bernt, Nan Zhu, Amit Sinha,

Cancer Cell

2011

883

H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias

Andrei V. Krivtsov, Zhaohui Feng, Madeleine E. Lemieux,

Cancer Cell

2008

547

Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML

Carola Reindl, Ksenia Bagrintseva, Sridhar Vempati,

Blood

2006

129

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

Carola Reindl, Hilmar Quentmeier, Konstantin Petropoulos,

Clinical Cancer Research

2009

116

Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL

Matthew C. Stubbs, Won-Il Kim, Megan Bariteau,

Clinical Cancer Research

2015

81

Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential

Sridhar Vempati, Carola Reindl, Seshu Kumar Kaza,

Blood

2007

30

Transformation by Oncogenic Mutants and Ligand-Dependent Activation of FLT3 Wild-type Requires the Tyrosine Residues 589 and 591

Sridhar Vempati, Carola Reindl, Ulla Wolf,

Clinical Cancer Research

2008

27

Page 1